Landfar Bio-medicine Co., Ltd (SHE:000504)
China · Delayed Price · Currency is CNY 8.24
+0.33 (4.17%)
Jun 23, 2026, 3:04 PM CST
Landfar Bio-medicine Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Net Income | 42.15 | 28.83 | -19.85 | -28.17 | -12.46 | -19.13 |
Depreciation & Amortization | 7.34 | 7.34 | 5.71 | 6.34 | 6.21 | 6.87 |
Other Amortization | 24.01 | 24.01 | 12.18 | 9.15 | 9.1 | 7.26 |
Loss (Gain) From Sale of Assets | -0 | -0 | -0.16 | -11.9 | -0.08 | -0.03 |
Asset Writedown & Restructuring Costs | 2.44 | 2.44 | 0.47 | 6.92 | 0.9 | 2.53 |
Loss (Gain) From Sale of Investments | -7.71 | -7.71 | -3.68 | -0.95 | 0.06 | 0.31 |
Provision & Write-off of Bad Debts | 12.67 | 12.67 | 12.3 | 26.08 | 23.79 | 17.11 |
Other Operating Activities | -109.65 | -6.46 | 7.47 | -0.13 | -2.39 | 0.38 |
Change in Accounts Receivable | -173.67 | -173.67 | -37.38 | 9.84 | 135.21 | 47.24 |
Change in Inventory | 2.58 | 2.58 | -25.41 | -6.18 | 4.82 | 4.29 |
Change in Accounts Payable | -4.86 | -4.86 | 54.04 | 25.96 | 1 | 40.89 |
Operating Cash Flow | -205.61 | -115.74 | 4.79 | 36.28 | 166.38 | 107.1 |
Operating Cash Flow Growth | - | - | -86.79% | -78.20% | 55.35% | - |
Capital Expenditures | -7.68 | -5.12 | -18.26 | -5.92 | -16.94 | -31.96 |
Sale of Property, Plant & Equipment | 0.01 | 0.02 | 0 | 17.72 | 0.33 | 0.07 |
Cash Acquisitions | -61.23 | -61.23 | 2.53 | - | - | - |
Divestitures | -10.86 | -10.86 | - | - | - | - |
Investment in Securities | 45 | 100 | -98.19 | 0.95 | 0.49 | 0 |
Other Investing Activities | 3.08 | 4.08 | 5.59 | - | - | 1.74 |
Investing Cash Flow | -31.69 | 26.89 | -108.33 | 12.75 | -16.12 | -30.15 |
Short-Term Debt Issued | - | - | - | - | 75.14 | 55.86 |
Long-Term Debt Issued | - | 269.01 | 18 | 28 | - | - |
Total Debt Issued | 269.01 | 269.01 | 18 | 28 | 75.14 | 55.86 |
Short-Term Debt Repaid | - | - | -159.79 | -3.77 | -145 | -41.96 |
Long-Term Debt Repaid | - | -38.05 | -39.54 | -66.97 | -3.17 | -3.24 |
Total Debt Repaid | -42.55 | -38.05 | -199.33 | -70.74 | -148.17 | -45.2 |
Net Debt Issued (Repaid) | 226.46 | 230.96 | -181.33 | -42.74 | -73.03 | 10.66 |
Issuance of Common Stock | - | - | - | 273.7 | - | - |
Common Dividends Paid | -3.03 | -2.37 | -0.91 | -3.21 | -2.4 | -2.12 |
Other Financing Activities | 55.87 | -0.31 | -0.67 | -1.12 | -9.72 | 0.47 |
Financing Cash Flow | 279.3 | 228.28 | -182.91 | 226.63 | -85.15 | 9.02 |
Foreign Exchange Rate Adjustments | -0 | -0 | 0 | 0 | 0 | 0 |
Net Cash Flow | 42 | 139.43 | -286.45 | 275.66 | 65.11 | 85.97 |
Free Cash Flow | -213.3 | -120.85 | -13.47 | 30.36 | 149.44 | 75.14 |
Free Cash Flow Growth | - | - | - | -79.68% | 98.89% | - |
Free Cash Flow Margin | -41.60% | -29.06% | -10.02% | 22.19% | 74.59% | 47.97% |
Free Cash Flow Per Share | -0.67 | -0.38 | -0.04 | 0.10 | 0.48 | 0.24 |
Cash Interest Paid | - | - | - | - | - | 0.13 |
Cash Income Tax Paid | 32.83 | 20.48 | 10.71 | 18.25 | 9.24 | 16.06 |
Levered Free Cash Flow | -247.93 | -210.28 | -6.16 | 44.79 | 148.96 | 94.32 |
Unlevered Free Cash Flow | -244.96 | -208.66 | -5.24 | 51.71 | 157.03 | 104.3 |
Change in Working Capital | -176.86 | -176.86 | -9.65 | 28.94 | 141.25 | 91.79 |